Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
488.7 USD | -0.69% | +2.99% | +20.12% |
Jul. 11 | Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $455 From $402 | MT |
Jul. 09 | RBC Raises Price Target on Vertex Pharmaceuticals to $431 From $421, Keeps Sector Perform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B | |
+147.53% | 12.37B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated, Q4 2013 Earnings Call, Jan 29, 2014